Yüklüyor......
Review on sodium-glucose cotransporter 2 inhibitor (SGLT2i) in diabetes mellitus and heart failure
SGLT-2 inhibitors are a novel class of anti-diabetic agents which act by inhibiting glucose reabsorption in proximal convoluted tubules of kidney. Apart from maintaining glucose homeostasis they exert a number of positive effects on the cardiovascular system like weight loss, decreasing blood pressu...
Kaydedildi:
| Yayımlandı: | J Family Med Prim Care |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wolters Kluwer - Medknow
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6618209/ https://ncbi.nlm.nih.gov/pubmed/31334145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/jfmpc.jfmpc_232_19 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|